BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7004811)

  • 1. Improved control in diabetes with continuous subcutaneous insulin infusion.
    Schiffrin A; Colle E; Belmonte M
    Diabetes Care; 1980; 3(6):643-9. PubMed ID: 7004811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term, ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients.
    Barbosa J; Menth L; Eaton J; Sutherland D; Freier EF; Najarian J
    Diabetes Care; 1981; 4(2):269-74. PubMed ID: 7011745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a portable insulin infusion pump for outpatient management of brittle diabetes.
    Kitabchi AE; Fisher JN; Burghen GA; Gaylord MS; Blank NM
    Diabetes Care; 1979; 2(5):421-4. PubMed ID: 510142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels.
    Tamborlane WV; Hintz RL; Bergman M; Genel M; Felig P; Sherwin RS
    N Engl J Med; 1981 Aug; 305(6):303-7. PubMed ID: 7017416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined continuous subcutaneous insulin infusion and multiple subcutaneous injections in type I diabetic patients.
    Schiffrin A; Belmonte M
    Diabetes Care; 1981; 4(6):595-600. PubMed ID: 6751734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between multi-injection and continuous subcutaneous insulin therapy in insulin-dependent diabetic inpatients.
    Saibene V; Melandri M; Brembilla L; Spotti D; Pozza G
    Acta Diabetol Lat; 1981; 18(1):45-50. PubMed ID: 7010856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 days.
    Pickup JC; Keen H; Parsons JA; Alberti KG
    Diabetologia; 1979 Jun; 16(6):385-9. PubMed ID: 467848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
    Selam JL; Slingeneyer A; Hedon B; Mares P; Beraud JJ; Mirouze J
    Diabetes Care; 1983; 6(2):105-11. PubMed ID: 6406198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion.
    Reeves ML; Seigler DE; Ryan EA; Skyler JS
    Am J Med; 1982 Apr; 72(4):673-80. PubMed ID: 7041646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.
    Pickup JC; Keen H; Parsons JA; Alberti KG
    Br Med J; 1978 Jan; 1(6107):204-7. PubMed ID: 340000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system.
    Tamborlane WV; Sherwin RS; Genel M; Felig P
    Am J Med; 1980 Feb; 68(2):190-6. PubMed ID: 6986766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of insulin-dependent diabetes with portable miniaturized infusion systems.
    Hepp KD; Renner R; Piwernetz K; Mehnert H
    Diabetes Care; 1980; 3(2):309-13. PubMed ID: 6993145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics.
    Pickup JC; Keen H; Parsons JA; Alberti KG; Rowe AS
    Lancet; 1979 Jun; 1(8129):1255-7. PubMed ID: 87724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
    Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term continuous subcutaneous insulin infusion in diabetics at home.
    Pickup JC; White MC; Keen H; Parsons JA; Alberti KG
    Lancet; 1979 Oct; 2(8148):870-3. PubMed ID: 90966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of an implantable insulin pump in the treatment of type II diabetes.
    Rupp WM; Barbosa JJ; Blackshear PJ; McCarthy HB; Rohde TD; Goldenberg FJ; Rublein TG; Dorman FD; Buchwald H
    N Engl J Med; 1982 Jul; 307(5):265-70. PubMed ID: 7045666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood sugar control in diabetics with the insulin pump. Comparison with discontinuous injections].
    Sudre Y; Abadie JC; Marechaud R; Rossi F; Gouet D; Queron B
    Sem Hop; 1982 Sep; 58(32):1801-4. PubMed ID: 6291163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous infusion of insulin in the management of diabetes mellitus.
    Champion MC; Shepherd GA; Rodger NW; Dupre J
    Diabetes; 1980 Mar; 29(3):206-12. PubMed ID: 6991323
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
    Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG
    Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of insulin-dependent diabetes with multiple subcutaneous insulin injections.
    Schiffrin A
    Med Clin North Am; 1982 Nov; 66(6):1251-67. PubMed ID: 6755093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.